UNSPSC 51453017: Piperazine sebacate

This classification denotes an antihelminthic agent C10H18O4.C4H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X1EUC610UJ, chemically known as decanedioic acid, compd. with piperazine (1:1), but more generally known as piperazine sebacate, which bears US NIH Compound Identifier 3084013. European Medicines Agency schedules Piperazine sebacate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03849MIG.

Most nations, for tariff and trade purposes, schedule piperazine sebacate under HS 29335990 and SITC 51576. As of Q4 2014, PIPERAZINE SEBACATE remains US FDA's Preferred Term for this commodity. SMILES: C1CNCCN1.C(CCCCC(=O)O)CCCC(=O)O.

UNSPSC 51453017 Piperazine sebacate is a Commodity code that in recent state and local procurement activity covers pharmaceutical and medical supply procurement more broadly, though the code's nominal chemical scope does not map cleanly to the opportunities actually being solicited. The recent contract opportunities soliciting under this code reflect state and local demand for naloxone and drug deactivation systems, generic pharmaceuticals and over-the-counter products through cooperative purchasing agreements, direct-to-manufacturer prescription fulfillment capabilities, and medical and first aid supplies for emergency response. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas), municipal fire departments (Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving member state and local facilities including Oregon). The activity suggests the code is capturing pharmaceutical procurement across health departments, emergency medical services, and cooperative purchasing vehicles rather than chemical compound supply in the narrower sense the code name suggests.

The most recent geographic activity concentrates in Florida, Texas, and Minnesota, with broader participation across the MMCAP network. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000.00 and a 5% SLBE bid discount not to exceed $10,000; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities. The Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment models, signaling emerging demand for alternative pharmacy benefit program structures. State and local buyers under this code prioritize competitive pricing, compliance with manufacturing and supply-chain security standards, and timely delivery to end-use locations.